Lably
Skip to content

Impact of the COVID-19 pandemic on the telehealth industry

Impact of coronavirus on telehealth

  • 8 min read
  • 4 chapters

Related on Lably

Through Massachusetts and Venture capital

Growth in the industry

Telehealth companies have witnessed substantial growth in their business operations since the onset of the pandemic, evident in the significant rise in both patient volume and financial prosperity. For instance, within a short span between February and March 2020, telehealth claims at the Blue Cross Blue Shield of Massachusetts escalated by an astounding 3,500%. NYU Langone Health's telehealth platform swiftly expanded by integrating over 1,300 new healthcare providers during the pandemic, highlighting the industry's meteoric surge. The COVID-19 outbreak facilitated an unprecedented reach for telehealth companies.

The influx of new clientele has propelled companies such as Teladoc, which had capitalized on this market. Evidently, Teladoc's stock valuation in 2020 increased year to date by 139%, while the industry's second-largest company, Amwell, went public on September 17, 2020. Collectively, the top 60 virtual health companies experienced a substantial increase in total revenue, increasing from $3 billion in 2019–2020 to $5.5 billion in 2020–2021. This growth had attracted interest from venture capitalists and other investors seeking to partake in the telehealth industry's expansion during the pandemic. Venture capital funding for telehealth companies in the initial quarter of 2020 rose to $788 million, a figure more than threefold compared to the funds raised in the corresponding period of 2019. Additionally, telehealth startups experienced a year-over-year increase of 1,818% in funding during 2020 .

Sign in to keep reading

3 more chapters are free with a Lably account.

More in Health